THE EFFECT OF THE ENZYME «GEMAZA» ON THE EFFECTINESS OF HEMOPHTHALMUS TREATMENT IN DIABETIC RETINOPATHY

Abstract

To study the comparative effectiveness of various routes of administration of Hemase and Emoxipin in the treatment of patients with hemophthalmia and diabetic retinopathy, in clinical studies, we analyzed the results of treatment of 46 patients with a proliferative stage of diabetic retinopathy complicated by hemophthalmus (49 eyes): in group I (n = 20), “Emoxipine” was administered parabulbarly; in II (n = 16) - in subconjunctives «Gemaza»; in III (n = 13) – intravitreal «Gemaza» . Within 30 days, the dynamics of visual acuity and hemophthalmus index, which were the same before treatment, as well as the frequency of hemorrhagic and allergic complications, were evaluated in patients. Intravitreal administration causes accelerated resorption of hemophthalmus and restoration of visual acuity in comparison with subconjunctival and parabulbar administration of Emoxipin, which allows retinal laser coagulation to begin earlier.